Funding
All authors participated in an SARS-CoV-2 expert panel convened between
February and June 2022, for which they received an honorarium sponsored
by Roche Diagnostics. Medical writing support and open access
publication fees were provided by Roche Diagnostics International Ltd,
Rotkreuz, Switzerland.